Condition
Esophageal Spasm, Diffuse
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting1
Unknown1
Withdrawn1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05905016Recruiting
Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders
NCT02663206Not ApplicableWithdrawn
Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in Spastic Esophageal Disorders
NCT01432782Not ApplicableUnknownPrimary
Botulinum Toxin Injection to Treat Diffuse Esophageal Spasm
Showing all 3 trials